First Ever Public Dengue Vaccination Programme of World Has Been Launched in Philippines (Download PDF)


Download PDF of This Page (Size: 165.15 K)

With a French drug Dengvaxia (world’s 1st dengue fever vaccine) to combat mosquito-borne disease the world’s first public dengue vaccination programme was launched in the Philippines. And in this program many hundred children whose age is between 9 and 10 were protected with the injections in front of government health workers at a public school in eastern Manila.

Key Facts:

  • Mexico becomes first country in to allow the world to approve first-ever Dengvaxia Dengue fever vaccine for the public use and Philippines.
  • But with the launch of first public dengue vaccination programme, Philippines became first country to announce, adopt and implement the first-ever dengue vaccine through the public health system and under public school settings.
  • Dengue or hemorrhagic fever is the world’s most common mosquito-borne virus according to the World Health Organization (WHO).
  • It contaminates a projected 390 million people in more than 120 countries each year, killing more than 25,000.
  • Asia is home to some 70 % of cases worldwide and in the Philippines 200,000 cases were reported in 2013.

About Dengue Fever:

  • Dengue fever is a vector-borne disease caused by a family of viruses that are transmitted by Aedes aegypti mosquitos’ species.
  • It is dominant through the tropics and subtropics.
  • It is also recognized as mosquito-borne tropical disease


  • Severe joint and muscle pain
  • Swollen lymph nodes
  • Headache
  • Fever
  • Exhaustion and rash


  • Prevent from Dengue require control or abolition of the mosquitoes carrying the virus that causes dengue.
  • There is no known cure and children are at particular risk.

- Published/Last Modified on: April 5, 2016

Govt. Schemes/Projects

Doorsteptutor material for CLAT GK-Current-Affairs is prepared by worlds top subject experts- fully solved questions with step-by-step exaplanation- practice your way to success.

Developed by: